Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
์ข
๋ชฉ ์ฝ๋ BDX
ํ์ฌ ์ด๋ฆBecton Dickinson and Co
์์ฅ์ผOct 31, 2099
CEOPolen (Thomas E)
์ง์ ์72000
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃOct 31
์ฃผ์One Becton Drive
๋์FRANKLIN LAKES
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ07417-1880
์ ํ12018476800
์น์ฌ์ดํธhttps://www.bd.com/
์ข
๋ชฉ ์ฝ๋ BDX
์์ฅ์ผOct 31, 2099
CEOPolen (Thomas E)